Marksans Pharma Ltd share price logo

Marksans Pharma Ltd (MARKSANS)

₹168.450.35%

bell
Get free price alerts. Set up your Free investment account to get Live Prices. >
Overview
Fundamentals
Q3 '23 Results
Technicals
News and Events

Marksans Pharma Ltd share Performance

  • ₹167.5
    ₹171.15
    ₹168.45
    downward going graph

    0.56%

    Low

    Day's Volatility:2.17%

    High

    1.60%

    downward going graph
  • ₹71.8
    ₹185.5
    ₹168.45
    downward going graph

    57.38%

    Low

    52 Weeks Volatility:67.50%

    High

    10.12%

    downward going graph
1 Month Return+ 0.78 %
3 Month Return+ 4.56 %
1 Year Return+ 130.12 %
Previous Close₹169.05
Open₹169.05
Volume8.47L
Upper Circuit-
Lower Circuit-
Market Cap₹7,660.73Cr

Company Information

Marksans Pharma Limited is a public limited company that specializes in research, manufacture, marketing and sale of pharmaceutical formulations. Established in April 1982, the Company has its research and development centers located in Verna Goa and Navi Mumbai. On 30th March 2015, they issued and allotted 24006494 equity shares of ₹1 each to qualified institutional buyers for ₹54.67 per share under QIP. On 7th February 2015, the Company decided to redeem 1350000 cumulative redeemable preference shares of face value ₹100 each out of profits in tranches before due date of redemption, which was decided to be 27th March 2018. 50000 Bonds of USD 1000 value each were issued during the financial year 2015, out of which 49939 Bonds were bought and extinguished by the Company. 150000 preference shares of ₹100 each were redeemed at par in 2017 and the issued, subscribed and paidup preference share capital was reduced to 1100000 of ₹100 each. Marksans Pharma Limited is a long-standing public limited company offering research, manufacture, marketing and sale of pharmaceutical formulations.

Share Price: ₹168.45 per share as on 24 May, 2024 04:01 PM
Market Capitalisation: ₹7,660.73Cr as of today
Revenue: ₹586.13Cr as on December 2023 (Q4 23)
Net Profit: ₹82.97Cr as on December 2023 (Q4 23)
Listing date: 21 Jan, 2002
Chairperson Name: Mark Saldanha
OrganisationMarksans Pharma Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Marksans Pharma Ltd

  • Marksans Pharma's Total Shareholder Returns Outpace Earnings Growth - 10 May, 2024

    Marksans Pharma has seen a total shareholder return of 647% over the last five years, outpacing its earnings per share growth of 35%. The stock price has risen by 633% in the same period. Despite a recent retracement of 6.9%, Marksans Pharma shareholders have received a total shareholder return of 102% over the past year.

  • Marksans Pharma Receives Observations from USFDA - 18 Apr, 2024

    Marksans Pharma's Goa-based plant received five inspectional observations in Form 483 from the USFDA. The company is working closely with the regulator to address these comprehensively within the stipulated time.

  • MIT Acquires Stake in Marksans Pharma - 16 Apr, 2024

    Shares of Marksans Pharma rose by 12% after Massachusetts Institute of Technology acquired a 1.45% stake in the company for Rs 104.28 crore. The pharma company's stock has delivered multibagger returns of approximately 124% over the last year.

Fundamentals of Marksans Pharma Ltd

Insights on Marksans Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 4.68% to 4.69% in Mar 2024 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, MARKSANS stock has moved up by 130.1%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, MARKSANS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 3.82% to 4.23% in Mar 2024 quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, MARKSANS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 496.99 Cr → 590.93 Cr (in ₹), with an average increase of 5.6% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 43.85% of holdings in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 83.52 Cr → 83.24 Cr (in ₹), with an average decrease of 0.3% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 35.83% to 35.40% in Mar 2024 quarter

Marksans Pharma Ltd Valuation

Marksans Pharma Ltd in the last 5 years

  • Overview

  • Trends

Lowest (4.67x)

April 1, 2020

Today (23.49x)

May 24, 2024

Industry (62.95x)

May 24, 2024

Highest (46.60x)

January 24, 2018

LowHigh

Mutual Fund Holdings

Funds Holdings
UTI Aggressive Hybrid Fund-Growth - DirectUTI Aggressive Hybrid Fund-Growth - Direct0.75%
UTI Small Cap Fund Direct GrowthUTI Small Cap Fund Direct Growth1.08%
UTI Large & Mid Cap Fund-Growth Option - DirectUTI Large & Mid Cap Fund-Growth Option - Direct0.82%
UTI Retirement Fund- DirectUTI Retirement Fund- Direct0.44%
UTI Healthcare Fund-Growth Option- DirectUTI Healthcare Fund-Growth Option- Direct1.46%

Shareholding Pattern

InvestorsHoldings %Prev. 1 periods3M change
Promoter Holdings
43.85%
0.00
Foreign Institutions
4.69%
0.00
Mutual Funds
4.23%
0.00
Retail Investors
35.4%
0.00
Others
11.83%
0.00

Technicals of Marksans Pharma Ltd share

News & Events of Marksans Pharma Ltd

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Marksans Pharma Ltd shares.

Marksans Pharma Ltd (MARKSANS) share price today is ₹168.45

Marksans Pharma Ltd is listed on NSE

Marksans Pharma Ltd is listed on BSE

  • Today’s highest price of Marksans Pharma Ltd is ₹171.15.
  • Today’s lowest price of Marksans Pharma Ltd is ₹167.5.

PE Ratio of Marksans Pharma Ltd is 23.49

PE ratio = Marksans Pharma Ltd Market price per share / Marksans Pharma Ltd Earnings per share

Today’s traded volume of Marksans Pharma Ltd(MARKSANS) is 8.47L.

Today’s market capitalisation of Marksans Pharma Ltd(MARKSANS) is ₹7660.73Cr.

Marksans Pharma Ltd(MARKSANSPrice
52 Week High
₹185.5
52 Week Low
₹71.8

Marksans Pharma Ltd(MARKSANS) share price is ₹168.45. It is down -9.19% from its 52 Week High price of ₹185.5

Marksans Pharma Ltd(MARKSANS) share price is ₹168.45. It is up 134.61% from its 52 Week Low price of ₹71.8

Marksans Pharma Ltd(MARKSANSReturns
1 Day Returns
-0.6%
1 Month Returns
0.78%
3 Month Returns
4.56%
1 Year Returns
130.12%